Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $296.22M. Across the group, the median move over the past trading day is +0.31%. Price change over the past year runs from −25.8% to +260.3% across the middle 80 percent of the group, with a median of −15.0%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% | Nov 4, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% | Nov 3, 2026 |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −14.98% | Nov 12, 2026 |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% | Nov 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.